A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
Status:
Completed
Trial end date:
2020-12-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety and effectiveness of experimental medication
BMS-986205 in combination with Nivolumab in patients with cancers that are advanced or have
spread.